Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$80.52 USD
+0.72 (0.90%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $80.53 +0.01 (0.01%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Corcept Therapeutics Incorporated's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CORT 80.52 +0.72(0.90%)
Will CORT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CORT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CORT
FDA Accepts Corcept's NDA for Relacorilant in Ovarian Cancer
Can Korlym Drive Corcept's Growth Through the Rest of 2025?
CORT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock?
CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down
Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates
Other News for CORT
Is CORT gaining bullish strength? Expansion Breakout shows up after surging 6.15%
CORT forms Directional Movement Crossover Bullish on September 18
CORT Crossed Above 20 Day Moving Average on September 16
CORT Fell Below 20 Day Moving Average on September 15
CORT forms Bollinger Band Squeeze on September 12